Clayton E. Mathews, PhD

Associate Professor





Dept. of Pathology, Immunology and Laboratory Medicine
University of Florida, College of Medicine
P.O. Box 100275
Gainesville, FL 32610-0275

Office Location and Express Mail address:
Dept. of Pathology, Immunology and Laboratory Medicine
University of Florida College of Medicine
JHMHSC R4-204 (office)
JHMHSC R4-156 (Lab 1)
JHMHSC R4-183 (Lab 2)
1600 SW Archer Rd
Gainesville, FL 32610-0275

Office: (352) 392-9803
Fax: (352) 392-5393
Email: clayton.mathews@pathology.ufl.edu

Grants Assistant:
Christy Popp (352) 392-2483

Currently Involved In:

Despite continuing improvements in the ability to treat individuals with type 1 diabetes (commonly referred to as juvenile diabetes), the need to identify a true cure for the disease remains. In an attempt to meet this need, Dr. Clayton Mathews performs studies seeking to improve our collective understanding on the means by which type 1 diabetes develops, both in humans as well as in mouse models of the disease. His efforts are extremely novel in that while the majority of type 1 diabetes researchers addressing the notion of how the disease develops focus on identifying defects in cells of the immune system, the guiding hypothesis of Dr. Mathews¹ research is that insulin secreting pancreatic beta cells are active contributors to the processes that leads to type 1 diabetes. This concept was birthed through early works by Dr. Mathews, demonstrating that beta cells had unusual reductions in their self-defense mechanisms and that this reduction was important in the initiation of type 1 diabetes. Later his studies demonstrated that beta cells from different strains of mice varied in their resistance to destruction by the immune system. These novel findings proved to be highly influential to the research community since prior to these efforts, evidence suggesting that beta cells could resist immune destruction did not exist. These findings also led Dr. Mathews to postulate that genetic factors related to this feature may underlie natural resistance to type 1 diabetes; a concept for which has recently found support. Dr. Mathews¹ continuing attempts to discover genes that beta cells naturally employ to ward off destructive mechanisms used by the immune system will undoubtedly have important ramifications for efforts in organ transplantation, stem cell engineering, and pharmacological based studies seeking to cure type 1 diabetes.

Related Links:

University of Florida Center for Immunology and Transplantation
American Diabetes Association
Juvenile Diabetes Research Foundation
Islet Cell Resource Centers
The National Institute of Diabetes and Digestive and Kidney Diseases

Curriculum Vitae

Primary Navigation